Digital Diagnostics

Digital Diagnostics is transforming healthcare with autonomous AI systems that enable a specialist diagnosis on the frontlines of care.

Digital Diagnostics is a leading AI diagnostic healthcare technology company on a mission to transform the quality, accessibility, and affordability of healthcare world-wide.

Founded in 2010 by a team of world-renowned clinician scientists, the company is focused on developing clinically-aligned autonomous algorithms that detect disease in medical images. The company’s first product, IDx-DR, is the first and only FDA-cleared AI-based diagnostic system for the autonomous detection of diabetic retinopathy.


Michael Abramoff


Founded 2010
Invested 2018